A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients.

A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common.

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.

Vanderbilt’s Thomas Powers, M.D., has learned to see exceptionally well in the dark.

Dylan Burnette, Ph.D., points to one of the many striking photographs on his office walls. It’s a picture of a cell — a microscopic image showing yellow squiggles, bright purple lines and a turquoise oval on a black background, and it looks like abstract art.

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.

Using imaging data, Vanderbilt researchers discovered an association between a gene pair and brain changes in Alzheimer’s disease.